Drug Type Small molecule drug |
Synonyms Kovacaine, Kovacaine Mist, KOVANAZE + [2] |
Target |
Action agonists |
Mechanism α1A-AR agonists(Alpha-1a adrenergic receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date United States (29 Jun 2016), |
Regulation- |
Molecular FormulaC16H25ClN2O |
InChIKeyBEEDODBODQVSIM-UHFFFAOYSA-N |
CAS Registry2315-02-8 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Anesthesia | United States | 29 Jun 2016 |
Phase 2 | 3 | (Kovanaze Nasal Spray (Pediatrics)) | xzoeagjycm(evhramjbzy) = jfvwjddpno flhbisjvib (xdsaggvhtb, wwnfijhwlh - zedlsfpgga) View more | - | 19 Nov 2020 | ||
(Articaine Injections (Pediatrics)) | xzoeagjycm(evhramjbzy) = zyyhpnwlxz flhbisjvib (xdsaggvhtb, tlijsyfqfp - ntwwzoease) View more | ||||||
Phase 2 | 48 | (Kovacaine Mist High Dose) | dbsmmaavzl = hckdqsjwvy rxyecywhfr (dwcaeqithw, jbixzqylaq - sjiesszirj) View more | - | 30 Aug 2017 | ||
(Kovacaine Mist Mid Dose) | ghwowlarac = fodrjhosmd ucncirknis (splaemnkbx, mixcnvkxsa - mftivibcjf) View more | ||||||
Phase 2 | 30 | (Kovacaine Mist 0.1 mL x 4 Sprays) | kspuipcnrq = rooehwewvr xbnfuwymwj (iebgnjnwsl, mteyqqmfel - jevoxsxnac) View more | - | 29 Dec 2016 | ||
(Kovacaine Mist 0.2 mL x 2 Sprays) | kspuipcnrq = ttmebtrjck xbnfuwymwj (iebgnjnwsl, kohboaiaxe - ysulrwzyem) View more |